2007
DOI: 10.1111/j.1524-4733.2007.00267.x
|View full text |Cite
|
Sign up to set email alerts
|

The Mayo Clinic Manuscript Series Relative to the Discussion, Dissemination, and Operationalization of the Food and Drug Administration Guidance on Patient-Reported Outcomes

Abstract: Patient-reported outcomes (PROs) have become increasingly prevalent in clinical research and practice. On February 2, 2006, the Food and Drug Administration (FDA) released a draft guidance document with respect to incorporating PROs into clinical research endeavors which include FDA involvement. Researchers at the Mayo Clinic worked with FDA personnel and experts from academia, industry, clinical research, and clinical practice to facilitate discussion, dissemination, and operationalization of the FDA guidance… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
24
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(24 citation statements)
references
References 17 publications
0
24
0
Order By: Relevance
“…without the interpretation of others [1]. The importance of PROs, as measured with patient-reported outcome measures (PROMs), is increasingly acknowledged in health care [2]. Examples of PROs are: pain, health-related quality of life (HRQoL), patients' experienced disease severity, treatment adherence and satisfaction with treatment.…”
Section: Introductionmentioning
confidence: 99%
“…without the interpretation of others [1]. The importance of PROs, as measured with patient-reported outcome measures (PROMs), is increasingly acknowledged in health care [2]. Examples of PROs are: pain, health-related quality of life (HRQoL), patients' experienced disease severity, treatment adherence and satisfaction with treatment.…”
Section: Introductionmentioning
confidence: 99%
“…4 Participants can report PROM-related health behaviors or physiological measurements (eg, blood glucose levels) in person at a clinic, on paper, or electronically using interactive voice response (IVR) telephone technology, computers, or smartphones. 5,6 PROM information reported to a patient's provider can be clinically useful and may help facilitate health behavior modification and disease management. 7 In addition, PROM data can be of great importance to research and has been used to determine eligibility for clinical trials, to strengthen communication with patients during clinical trials, and to determine treatment effectiveness.…”
mentioning
confidence: 99%
“…Among men in a stable relationship-those who had the regular opportunity to engage in sexual activity-who attempted sexual intercourse and activity in the past 4 weeks, levels of ED severity on the EF domain have been classified as follows: normal (no ED; score, 26-30); mild ED (22)(23)(24)(25); mild-to-moderate (17-21); moderate (11)(12)(13)(14)(15)(16)) and severe (6)(7)(8)(9)(10). 19,[41][42] For men in a stable relationship whose ED is so poor that they do not even attempt sexual activity, the severe ED scores range from 1 to 10.…”
Section: Erectile Function Domain Of the Iiefmentioning
confidence: 99%
“…A detailed review article on the SEAR questionnaire is published elsewhere. 27 Briefly, the 14 chosen items on SEAR questionnaire clustered into two domains: Sexual Relationship Satisfaction (items [1][2][3][4][5][6][7][8] and Confidence (items 9-14), the latter comprising Self-Esteem (items 9-12) and Overall Relationship Satisfaction (items 13-14) subscales (Table 5). As with the QEQ, the SEAR questionnaire has its constituent item responses summed to arrive at an individual's actual raw score for each domain and subscale, as well as his overall score, and the corresponding actual raw score is then transformed onto a 0-100 scale: transformed score ¼ 100 Â ((Actual raw scoreÀLow-est possible raw score)/Possible raw score range).…”
Section: Self-esteem and Relationship Questionnairementioning
confidence: 99%
See 1 more Smart Citation